Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is unchanged from the number of companies cited in the previous year.
The citations in the county include:
- You offered a food-producing animal(s) for interstate commerce that was found to bear or contain a drug residue in an edible tissue above an established safe level, safe concentration, or tolerance.
- You did not maintain complete treatment records.
- You did not prepare a written master manufacturing record for each unique formulation of a dietary supplement that you manufactured.
Both companies cited should take voluntary actions to correct their managing operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
Company Name | Area of Business | Inspection Date | Issue Cited |
---|---|---|---|
NeuroScience Solutions, Inc. | Food and Cosmetics | 07/01/2024 | Master manufacturing record - unique formulation |
Ulrich Farms | Veterinary | 01/12/2024 | Introduction/delivery into IS - illegal drug residue |
Ulrich Farms | Veterinary | 01/12/2024 | Record keeping |